GSK Nutritional Healthcare chooses a BT Cloud Contact solution to improve service on vital customer help lines powered by Enghouse Interactive

Care isn’t just part of the name at GSK Nutritional Healthcare. It’s at the heart of its customer help lines. But Ashley Thomas knew that the company’s legacy telephone technology was becoming a bit of a hindrance. Keen to boost customer service with new technology, a review of the market led Ashley to BT Cloud Contact

Sanofi/GSK launch Phase III trial of COVID-19 vaccine, will test efficacy against variants

[Swedish] Högskolorna í övre Mesopotamíen: Del I - Edessa, Nsibin och Qartëmin

Drugmaker GlaxoSmithKline (GSK) and Comic Relief has formed a five-year partnership to reduce the global malaria burden by 2030. Comic relief and GSK

Kharʹkov : "Folio", [2020]

The company is listed in India for over six decades, has brands that are as old as the country

New partnership is part of GSK’s R&D face-lift, which includes an increased focus on immune system targets

Hindustan Unilever share price jumped 4% on Friday to trade at Rs 2,070 per share on the NSE Nifty-50 after a bulk deal that saw French multinational investment bank and financial services company, Societe Generale buy 1,29,00,000 shares.

GSK Nutritional Healthcare chooses a BT Cloud Contact solution to improve service on vital customer help lines powered by Enghouse Interactive

Care isn’t just part of the name at GSK Nutritional Healthcare. It’s at the heart of its customer help lines. But Ashley Thomas knew that the company’s legacy telephone technology was becoming a bit of a hindrance. Keen to boost customer service with new technology, a review of the market led Ashley to BT Cloud Contact

The 5.7% stake in Hindustan Unilever that is now on the market, was accepted by GSK as payment for the sale of the malted drink brand and other nutrition brands to Unilever, agreed in late 2018.

GlaxoSmithKline and Horlicks have sold 5.7 per cent equity of HUL worth Rs 26,000 crore on Thursday to domestic and foreign investors.

Der Türkei macht der erneute Absturz der Lira zu schaffen. Für einen Euro wurde am Dienstag zeitweise bis zu 7,62 Lira gezahlt. Das Land war bereits zuvor finanzwirtschaftlich angeschlagen - wegen politischen Streits zwischen der Türkei und den USA.

This sensitive, dynamic recording is a joy, and may even constitute a revelation.

I didn’t go to the joint meetings (JMM) this year. This is despite the following good reasons I had to go:  I’m in my fifth year, applying for jobs, and this is the time when you’re supposed to get out … Continue reading →

Berlin : T.C.F. Enslin, 1830.

Gepotidacin, a triazaacenaphthylene bacterial type II topoisomerase inhibitor, is in development for treatment of uncomplicated urinary tract infection (uUTI). This Phase 2a study in female participants with uUTI evaluated the pharmacokinetics (primary objective), safety, and exploratory efficacy of gepotidacin. Eligible participants (N = 22) were confined to the clinic at baseline, received oral gepotidacin 1,500 mg twice daily for 5 days (on-therapy; Days 1 to 5), and returned to the clinic for test-of-cure (Days 10 to 13) and follow-up (Day 28±3). Pharmacokinetic, safety, clinical, and microbiological assessments were performed. Maximum plasma concentrations were observed approximately 1.5 to 2 hours postdose. Steady state was attained by Day 3. Urinary exposure over the dosing interval increased from 3,742 μg.h/ml (Day 1) to 5,973 μg.h/ml (Day 4), with trough concentrations of 322 to 352 μg/ml from Day 3 onward. Gepotidacin had an acceptable safety-risk profile with no treatment-limiting adverse events and no clinically relevant safety trends. Clinical success was achieved in 19 (86%) and 18 (82%) of 22 participants at test-of-cure and follow-up, respectively. Eight participants had a qualifying baseline uropathogen (growth; ≥10⁵ CFU/ml). A therapeutic (combined clinical and microbiological [no growth; <10³ CFU/ml]) successful response was achieved in 6 (75%) and 5 (63%) of 8 participants at test-of-cure and follow-up, respectively. Plasma area under the free-drug concentration-time curve over 24 hours at steady state divided by the MIC (fAUC_0-24/MIC) and urine AUC_0-24/MIC ranged from 6.99 to 90.5 and 1,292 to 121,698, respectively. Further evaluation of gepotidacin in uUTI is warranted. (NCT03568942)

ग्लैक्सोस्मिथक्लाइन पीएलसी (जीएसके) ने भारत की प्रमुख एफएमसीजी कंपनी हिंदुस्तान यूनिलीवर में 5.7 फीसदी हिस्सेदारी लगभग 25,480 करोड़ रुपये में बेच दी है।

British multinational GlaxoSmithKline have hired computational drug design expert Dr Kim Branson as the company’s new Senior Vice President, Global Head of Artificial Intelligence and Machine Learning.

In his new role, the biotech veteran will oversee projects which use AI to identify novel targets for potential medicines.

Dr Branson brings to the role more than 15 years’ worth of experience in biotech and academia having held positions at a number of Silicon Valley firms including Gliimpse, Lumia and Hessian Informatics.

read more

Business chief Jonathan Symonds has joined British multinational GlaxoSmithKline as the company’s new non-executive chairman.

The hire ends GSK’s six month search, as it prepares to fold its consumer business into a joint venture with Pfizer. In his new role Symonds will oversee the changes being implemented by CEO Emma Walmsley who joined GSK in 2017. Walmsley hopes to revitalise GSK’s R&D efforts with the help of Chief Scientific Officer Hal Barron.

read more

Two companies jointly have capacity to manufacture hundreds of millions of doses

• Coronavirus – latest updates
• See all our coronavirus coverage

Two of the world’s biggest vaccine companies have joined forces in an “unprecedented” collaboration to develop a Covid-19 vaccine.

GlaxoSmithKline and Sanofi, which combined have the largest vaccine manufacturing capability in the world, are working together on a hi-tech vaccine they say could be in human trials within months.

What is Covid-19?

GlaxoSmithKline has completed divestment of its Horlicks and other Consumer Healthcare nutrition products…

GlaxoSmithKline is hard at work with partner Sanofi in getting a vaccine tested for COVID-19, but this morning it said it was now also entering the race to treat patients already hit with the disease.

The Swedish word, which translates to 'flight shame', is driving interest in climate-friendly trains, longer stays, and frequent flier taxes.

This investment is in addition to Rs 1,000 crore investment for a greenfield plant in Bengluru announced last year

Drug otilimab - in which GSK acquired rights from German biotech firm Morphosys in 2013 - may possibly ease the devastating effect of the virus on the lungs, while not suppressing the virus directly, a company spokesman said.

According to the term sheet, an over 133 million shares - 5.7 per cent of the total equity shares - are being offered in the range of Rs 1,850-1,950 to investors through a special block window.

GlaxoSmithKline (GSK) is creating a data-focused culture and a global machine-learning team.

Schleifer, Tobias, author

GlaxoSmithKline is selling $3.45 billion worth of shares in Unilever's Indian business on the open market, one of the bookrunners organising the transaction said. The 5.7% stake in Hindustan Unilever, now put on the market, was accepted by GSK as payment for the sale of malted drink brand Horlicks and other nutrition brands to Unilever, agreed in late 2018.

Online Resource

Online Resource

STACK SCORE Mu pts M877 cop537 ar a

$367,172 grant targets "summer slide" through science education program

Sessions are available in nine counties.

Hayden Library - QC793.3.F5 M35 2019

Organ sheet music by Modest Mussorgsky | Meditation (arr. by A. Eaglefield Hull)

Organ sheet music by Modest Mussorgsky | Une Larme (arr. by A. Eaglefield Hull)